首页|保守类素化相关蛋白同源蛋白3介导拟素化通路在膀胱尿路上皮癌中的表达及其临床意义

保守类素化相关蛋白同源蛋白3介导拟素化通路在膀胱尿路上皮癌中的表达及其临床意义

扫码查看
目的 检测不同临床分期膀胱尿路上皮癌组织中神经前体细胞表达发育下调的蛋白8(NEDD8)、保守类素化相关蛋白同源蛋白3(DCNL3)和泛素结合酶E2M(UBE2M)的表达水平,并观察DCNL3对骨架蛋白Cullin1和Cullin3拟素化修饰的调控作用,探讨DCNL3介导拟素化通路在膀胱尿路上皮癌中的表达及临床意义。方法 选用郑州大学第一附属医院2020年3月至2023年5月行手术切除并经病理证实的膀胱尿路上皮癌标本59例,每例标本均选用癌组织中心及其远端正常黏膜对照。采用实时荧光定量反转录-聚合酶链反应(RT-PCR)和免疫组织化学技术检测切除标本中的NEDD8,DCNL3和UBE2M的表达;使用过表达/沉默DCNL3基因及蛋白质印迹法(Western blot)检测膀胱癌细胞株T24中骨架蛋白Cullin1和Cullin3的拟素化水平。组间比较采用两独立样本t检验。患者临床病理特征的分析采用x2检验。结果 DCNL3、UBE2M和NEDD8在膀胱尿路上皮癌组织中的表达明显高于正常黏膜(0。613±0。167比0。985±0。205、1。223±0。558比1。874±0。245、1。639±0。212 比 2。187±0。335,t=1。933、2。142、2。025,P<0。05),差异有统计学意义;其在肌层浸润性尿路上皮癌中的表达高于非肌层浸润性(0。738±0。188比1。245±0。155、1。566±0。385 比 2。532±0。466、1。933±0。485 比 2。748±0。515,t=2。106、2。767、2。367,P<0。05),差异有统计学意义,与临床分期明显相关。高表达DCNL3能够促进底物蛋白Cullin1[(78。55±6。34)%比(35。15±5。32)%,t=26。22,P<0。05]和 Cullin3[(66。82±5。66)%比(22。52±4。66)%,t=22。05,P<0。05]的拟素化水平。结论 DCNL3表达水平与膀胱尿路上皮癌临床分期明显相关,并可能通过调控底物骨架蛋白Cullin1和Cullin3拟素化水平,促进膀胱癌进展。
Expression and clinical significance of DCN1-like protein 3 mediated neddylation pathway in bladder urothelial carcinoma
Objective To detect the expression level of neural precursor cell expressed develop-mentally downregulated 8(NEDD8),DCN1-like protein 3(DCNL3)and ubiquitin conjugating enzyme E2M(UBE2M)in the different clinical stages of bladder urothelial carcinoma,observe the effect of DCNL3 on the neddylation of Cullin1 and Cullin3 skeleton protein by interfering with DCNL3 expression,and ex-plore the relationship between neddylation pathway mediated by DCNL3 and clinical pathological features of bladder urothelial carcinoma.Methods In total,59 bladder urothelial carcinoma specimens that were sur-gically resected and pathologically confirmed from the First Affiliated Hospital of Zhengzhou University from March 2020 to May 2023 were selected.Cancer tissue center and its distal normal mucosa were used as controls for each specimen.Real-time fluorescence quantitative reverse transcription-polymerase chain reac-tion(RT-PCR)and immunohistochemical techniques were used to detect the expression of NEDD8,DCNL3 and UBE2M in excised specimens.The levels of Cullin1 and Cullin3 in bladder cancer cell line T24 were detected by overexpression/silencing of DCNL3 gene and Western blotting.The clinicopathologic features of the patients were analyzed by x2 test.Results The expression rate of NEDD8,DCNL3 and UBE2M was significantly higher in bladder urothelial carcinoma than in normal tissues(0.613±0.167 vs.0.985±0.205,1.223±0.558 vs.1.874±0.245,1.639±0.212 vs.2.187±0.335,t=1.933,2.142,2.025,P<0.05).The expression rate of NEDD8,DCNL3 and UBE2M in muscle invasive blad-der cancer group was significantly higher than that in non-muscle invasive group(0.738±0.188 vs.1.245±0.155,1.566±0.385 vs.2.532±0.466,1.933±0.485 vs.2.748±0.515,t=2.106,2.767,2.367,P<0.05),which was related with the degree of tumor differentiation and tumor depth of invasion.High expression of DCNL3 promoted substrate protein Cullin1[(78.55±6.34)%vs.(35.15±5.32)%,t=26.22,P<0.05],and Cullin3[(66.82±5.66)%vs.(22.52±4.66)%,t=22.05,P<0.05]neddylation.Conclusion The expression of DCNL3 was related with the clinical stages of bladder urothelial carcinoma through the regulation of Cullin1/Cullin3 neddylation,which mediates the development of bladder urothelial carcinoma.

DCN1-like protein 3Cullin1Cullin3NeddylationBladder urothelial carci-noma

薛世龙、刘骅、李冠儒、王宁、顾朝辉、张雪培、王智宇

展开 >

郑州大学第一附属医院泌尿外科,郑州 450052

保守类素化相关蛋白同源蛋白3 骨架蛋白Cullin1 骨架蛋白Cullin3 拟素化 膀胱尿路上皮癌

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(9)